PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB
The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof. La présente invention concerne des com...
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
19.09.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof.
La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci. |
|---|---|
| AbstractList | The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof.
La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci. |
| Author | KOCHHAR, CHARU STINGELIN, DORIS ELBAZ, FRANTZ BOCK, MICHAELA ANNA MARIA |
| Author_xml | – fullname: ELBAZ, FRANTZ – fullname: STINGELIN, DORIS – fullname: KOCHHAR, CHARU – fullname: BOCK, MICHAELA ANNA MARIA |
| BookMark | eNrjYmDJy89L5WQwCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PcLBnOCPIM9_dwVHH0CXH2ATCceBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLv7GhkaWZkbmjibExYBQC4KyeT |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ALPELISIB |
| ExternalDocumentID | CA2962714C |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CA2962714C3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:49:16 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CA2962714C3 |
| Notes | Application Number: CA20152962714 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230919&DB=EPODOC&CC=CA&NR=2962714C |
| ParticipantIDs | epo_espacenet_CA2962714C |
| PublicationCentury | 2000 |
| PublicationDate | 20230919 |
| PublicationDateYYYYMMDD | 2023-09-19 |
| PublicationDate_xml | – month: 09 year: 2023 text: 20230919 day: 19 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | NOVARTIS AG |
| RelatedCompanies_xml | – name: NOVARTIS AG |
| Score | 3.5009856 |
| Snippet | The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230919&DB=EPODOC&locale=&CC=CA&NR=2962714C |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANBmi8e0C9VbCRvg4VatOWFq0PdR3abUofE1zGxIr4-zhRC1x2y0NyEkuO7cT-DHCHOs9AtTpS9NIgCtEJU1hpaIqp6fqSqIyRSqB9xlowIy9zdd6Dty4XRuCEfgtwRJSoEuW9Eff1-u8RyxWxlZv74h2HPp783HLl1jtGe9pECXQdy0sTN6EypRa15TizxrzIzIjQHdjlRjRH2fdeHZ6Tsv6vUPwj2EuR1qo5hl69GsAB7equDWA_ar-7sdlK3uYEHtLAziKberOcIxhINInSZBqKJGDRycJpGD9L9iT1Jth0TuHW93IaKLj04veUC2p3e3w8gz76_vUQpKVZm6U6LgUQvKoxhv5cQSqToRVhqBU5h-E2Khfbpy7hkPOKhz2MzCvoN59f9TXq1qa4EWz5ASGCeNs |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwbDNB4rge0WwXd0tehQl3a0UJf6jq025Q-JriMiRXx93GiDrjslofkJJYc24n9GeAOdZ6BalWR9cIgMtEJk1lhaLKp6fqSqIyRUqB9Rpo3I89zdd6Ct20ujMAJ_RbgiChRBcp7Le7r9d8jliNiKzf3-TsOfTxOMssZNN4x2tMmSqAzttwkdmI6oNSi9iBKrSEvMqMQugf7Osfm5YbT65jnpKz_K5TJMRwkSGtVn0CrWnWhQ7d117pwGDbf3dhsJG9zCg-JZ6ehTd1ZxhEMJBqHSTz1RRKw6KT-1I-eJDtI3ACb4zPoT9yMejIuvfg95YLa2z2OzqGNvn_VA2lpVmahDgsBBK9qjKE_l5PSZGhFGGpJLqC3i8rl7qk-dLwsDBaBH71cwRHnGw-BUMxraNefX9UN6tk6vxUs-gHv83vI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITIONS+COMPRISING+ALPELISIB&rft.inventor=ELBAZ%2C+FRANTZ&rft.inventor=STINGELIN%2C+DORIS&rft.inventor=KOCHHAR%2C+CHARU&rft.inventor=BOCK%2C+MICHAELA+ANNA+MARIA&rft.date=2023-09-19&rft.externalDBID=C&rft.externalDocID=CA2962714C |